硅谷银行（SVB）：2023年女性健康创新报告（英文版）（23页）.pdf

1、December 2023For millions of women,its an all too-familiar scene.Sitting in an exam room describing medical concerns to a trusted physician,yet not feeling heard.More than one in three women say a doctor either did not believe them,assumed something about them without asking or blamed them for a hea

2、lth problem.1Study after study shows that bias in healthcare disproportionately impacts outcomes for women,often leading to delayed diagnosis,misdiagnosis or undertreatment.The inequality and bias pervades deeper than the healthcare experience into the science itself.Women are underrepresented acros

3、s all steps of the R&D continuum,from data collection to clinical trials to outcome measurement.Diseases impacting women receive significantly less federal research funding than diseases impacting men(of the same burden).However,momentum to solve these systemic issues is building.In November,the Bid

4、en administration announced the first-ever womens health research initiative,a partnership between academics,doctors,patient-advocates and policymakers to recommend concrete steps for improvement in womens health research and funding.In our inaugural Innovation in Womens Health report,we leverage SV

5、Bs unmatched data and sector expertise to dive into the trends propelling this space forward.Despite headwinds in the larger venture capital(VC)landscape and the many obstacles facing this space,our analysis reveals an optimistic picture for womens health,which is undervalued and quickly growing com

6、pared to other healthcare sectors.Investors and companies are challenging the misconception that womens health is restricted to reproductive years and realizing the enormous opportunity to meet womens health needs throughout their lives.Investments are increasingly shifting into emerging areas such